- Home
- BMRN vs HST Comparison
BMRN vs HST Comparison
Compare BMRN & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | HST |
|---|---|---|
| Founded | 1996 | 1927 |
| Country | United States | United States |
| Employees | N/A | 163 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 11.9B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | HST |
|---|---|---|
| Price | $53.19 | $17.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $88.42 | $18.65 |
| AVG Volume (30 Days) | 3.0M | ★ 7.6M |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 5.21% |
| EPS Growth | ★ 59.53 | 3.27 |
| EPS | ★ 2.68 | 1.06 |
| Revenue | $3,094,001,000.00 | ★ $5,950,000,000.00 |
| Revenue This Year | $13.39 | $6.31 |
| Revenue Next Year | $7.57 | $1.80 |
| P/E Ratio | $19.92 | ★ $16.31 |
| Revenue Growth | ★ 12.39 | 6.44 |
| 52 Week Low | $50.76 | $12.22 |
| 52 Week High | $73.51 | $19.37 |
Technical Indicators
Market Signals| Indicator | BMRN | HST |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 50.20 |
| Support Level | $53.03 | $17.09 |
| Resistance Level | $54.66 | $17.69 |
| Average True Range (ATR) | 1.45 | 0.37 |
| MACD | -0.11 | -0.04 |
| Stochastic Oscillator | 31.61 | 43.53 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.